Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Esophageal Cancer (Oncology) - Drugs In Development, 2021
US$ 2,500.00
Esophageal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Esophageal Cancer - Drugs In Development, 2021, pr...
July 2021
2058 pages
Fibrosarcoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Fibrosarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosarcoma - Drugs In Development, 2021, provides an...
July 2021
202 pages
Free Fatty Acid Receptor 1 - Drugs In Development, 2021
US$ 3,500.00
Free Fatty Acid Receptor 1 - Drugs In Development, 2021 SUMMARY According to the recently published report 'Free Fatty Acid Receptor 1 - Drugs In Development, 2021'; Free Fatty Acid Receptor 1 (G Prot...
July 2021
69 pages
Glaucoma (Ophthalmology) - Drugs In Development, 2021
US$ 2,500.00
Glaucoma (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glaucoma - Drugs In Development, 2021, provides an ove...
July 2021
470 pages
Heavy Metal Poisoning - Drugs In Development, 2021
US$ 2,000.00
Heavy Metal Poisoning - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heavy Metal Poisoning - Drugs In Development, 2021, provi...
July 2021
36 pages
Heparanase - Drugs In Development, 2021
US$ 3,500.00
Heparanase - Drugs In Development, 2021 SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 15 molecules. Out of which approximately 14...
July 2021
63 pages
Hepatocyte Growth Factor - Drugs In Development, 2021
US$ 3,500.00
Hepatocyte Growth Factor - Drugs In Development, 2021 SUMMARY Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Hepatocyte growth factor (HGF) is a paracrine cellular growth and mo...
July 2021
99 pages
High Mobility Group Protein B1 - Drugs In Development, 2021
US$ 3,500.00
High Mobility Group Protein B1 - Drugs In Development, 2021 SUMMARY According to the recently published report 'High Mobility Group Protein B1 - Drugs In Development, 2021'; High Mobility Group Protei...
July 2021
57 pages
Hodgkin Lymphoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Hodgkin Lymphoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma - Drugs In Development, 2021, prov...
July 2021
1353 pages
